LinKinVax Just Completed a New Round of Financing, Initiated in 2022, for a Total of €7,3 M finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
TO ACCELERATE THE DEVELOPMENT OF ITS INNOVATIVE VACCINE PLATFORM LinKinVax, a clinical-stage biotechnology companyis announcing completion of a €4.350 million seed capital funding round. It was led
LinKinVax, a clinical-stage biotech company, is announcing the signing of an exclusive worldwide licensing agreement with Inserm Transfert to develop a vaccine strategy with an innovative mechanism of